Safety of apixaban for venous thromboembolism prophylaxis: the evidence to date

Safety of apixaban for venous thromboembolism prophylaxis: the evidence to date

Vladimir Trkulja Department of Pharmacology, Zagreb University School of Medicine, Zagreb, Croatia Abstract: Apixaban, a direct orally active anticoagulant (selective, direct factor Xa inhibitor) is approved for (primary) prevention of venous thromboembolism (VTE) in patients undergoing elective to...

Full description

Bibliographic Details
Main Author: Trkulja V
Format: Article
Language:English
Published: Dove Medical Press 2016-02-01
Series:Drug, Healthcare and Patient Safety
Subjects:
apixaban
venous thromboembolism
treatment
prophylaxis
safety
Online Access:https://www.dovepress.com/safety-of-apixaban-for-venous-thromboembolism-prophylaxis-the-evidence-peer-reviewed-article-DHPS

Internet

https://www.dovepress.com/safety-of-apixaban-for-venous-thromboembolism-prophylaxis-the-evidence-peer-reviewed-article-DHPS

Similar Items